{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:54:38Z","timestamp":1773248078991,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40659-019-0230-y","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T09:09:19Z","timestamp":1555492159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["PELI3 mediates pro-tumor actions of down-regulated miR-365a-5p in non-small cell lung cancer"],"prefix":"10.1186","volume":"52","author":[{"given":"Yuzheng","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yantao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"230_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","volume":"893","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1\u201319.","journal-title":"Adv Exp Med Biol"},{"key":"230_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"230_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.soc.2016.02.003","volume":"25","author":"M Zheng","year":"2016","unstructured":"Zheng M. Classification and pathology of lung cancer. Surg Oncol Clin N Am. 2016;25:447\u201368.","journal-title":"Surg Oncol Clin N Am"},{"key":"230_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/EdBook_AM.2013.33.359","volume":"33","author":"Graham W. Warren","year":"2013","unstructured":"Warren GW, Cummings KM. Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. In: American Society of Clinical Oncology educational book; 2013. p. 359\u201364.","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"230_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/rccm.201410-1777CI","volume":"191","author":"LT Tanoue","year":"2015","unstructured":"Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015;191:19\u201333.","journal-title":"Am J Respir Crit Care Med"},{"key":"230_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1200\/JCO.2013.53.1228","volume":"32","author":"DH Johnson","year":"2014","unstructured":"Johnson DH, Schiller JH, Bunn PA Jr. Recent clinical advances in lung cancer management. J Clin Oncol. 2014;32:973\u201382.","journal-title":"J Clin Oncol"},{"key":"230_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-4614-8778-4_5","volume":"799","author":"T Hensing","year":"2014","unstructured":"Hensing T, Chawla A, Batra R, Salgia R. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Adv Exp Med Biol. 2014;799:85\u2013117.","journal-title":"Adv Exp Med Biol"},{"key":"230_CR8","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.4049\/jimmunol.171.3.1500","volume":"171","author":"LE Jensen","year":"2003","unstructured":"Jensen LE, Whitehead AS. Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein. J Immunol. 2003;171:1500\u20136.","journal-title":"J Immunol"},{"key":"230_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1042\/BJ20071365","volume":"409","author":"A Ordureau","year":"2008","unstructured":"Ordureau A, Smith H, Windheim M, Peggie M, Carrick E, Morrice N, Cohen P. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem J. 2008;409:43\u201352.","journal-title":"Biochem J"},{"key":"230_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2429","volume":"13","author":"J Siednienko","year":"2012","unstructured":"Siednienko J, Jackson R, Mellett M, Delagic N, Yang S, Wang B, Tang LS, Callanan JJ, Mahon BP, Moynagh PN. Pellino3 targets the IRF7 pathway and facilitates autoregulation of TLR3- and viral-induced expression of type I interferons. Nat Immunol. 2012;13:1055\u201362.","journal-title":"Nat Immunol"},{"key":"230_CR11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.4161\/auto.32178","volume":"10","author":"AK Giegerich","year":"2014","unstructured":"Giegerich AK, Kuchler L, Sha LK, Knape T, Heide H, Wittig I, Behrends C, Brune B, von Knethen A. Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression. Autophagy. 2014;10:1937\u201352.","journal-title":"Autophagy"},{"key":"230_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35:3\u201311.","journal-title":"Semin Liver Dis"},{"key":"230_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-62703-703-7_2","volume":"1095","author":"M Hesse","year":"2014","unstructured":"Hesse M, Arenz C. MicroRNA maturation and human disease. Methods Mol Biol. 2014;1095:11\u201325.","journal-title":"Methods Mol Biol"},{"key":"230_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143\u201359.","journal-title":"EMBO Mol Med"},{"key":"230_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2014.11.013","volume":"41","author":"S Yang","year":"2014","unstructured":"Yang S, Wang B, Humphries F, Hogan AE, O\u2019Shea D, Moynagh PN. The E3 ubiquitin ligase Pellino3 protects against obesity-induced inflammation and insulin resistance. Immunity. 2014;41:973\u201387.","journal-title":"Immunity"},{"key":"230_CR16","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.12659\/MSM.909633","volume":"24","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Wen X, Zhao P. MicroRNA-365 inhibits cell growth and promotes apoptosis in melanoma by targeting BCL2 and cyclin D1 (CCND1). Med Sci Monit. 2018;24:3679\u201392.","journal-title":"Med Sci Monit"},{"key":"230_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12935-018-0563-6","volume":"18","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhang S, Bao H, Mu S, Zhang B, Ma H, Ma S. MicroRNA-365 promotes lung carcinogenesis by downregulating the USP33\/SLIT2\/ROBO1 signalling pathway. Cancer Cell Int. 2018;18:64.","journal-title":"Cancer Cell Int"},{"key":"230_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.yexcr.2017.12.001","volume":"362","author":"QH Min","year":"2018","unstructured":"Min QH, Wang XZ, Zhang J, Chen QG, Li SQ, Liu XQ, Li J, Liu J, Yang WM, Jiang YH, et al. Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365. Exp Cell Res. 2018;362:386\u201393.","journal-title":"Exp Cell Res"},{"key":"230_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cellsig.2013.11.003","volume":"26","author":"S Hamada","year":"2014","unstructured":"Hamada S, Masamune A, Miura S, Satoh K, Shimosegawa T. MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX. Cell Signal. 2014;26:179\u201385.","journal-title":"Cell Signal"},{"key":"230_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopha.2017.12.086","volume":"98","author":"Y Xu","year":"2018","unstructured":"Xu Y, Chu H, Zhou Y, Wang J, Dong C, Yin R. miR-365 functions as a tumor suppressor by directly targeting CYR61 in osteosarcoma. Biomed Pharmacother. 2018;98:531\u20137.","journal-title":"Biomed Pharmacother"},{"key":"230_CR21","first-page":"1705","volume":"8","author":"Z Chen","year":"2015","unstructured":"Chen Z, Huang Z, Ye Q, Ming Y, Zhang S, Zhao Y, Liu L, Wang Q, Cheng K. Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8:1705\u201311.","journal-title":"Int J Clin Exp Pathol"},{"key":"230_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3233\/CBM-150500","volume":"15","author":"J Bai","year":"2015","unstructured":"Bai J, Zhang Z, Li X, Liu H. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression. Cancer Biomark. 2015;15:599\u2013608.","journal-title":"Cancer Biomark"},{"key":"230_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biocel.2015.06.009","volume":"65","author":"L Zhou","year":"2015","unstructured":"Zhou L, Wang Y, Ou C, Lin Z, Wang J, Liu H, Zhou M, Ding Z. microRNA-365-targeted nuclear factor I\/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma. Int J Biochem Cell Biol. 2015;65:182\u201391.","journal-title":"Int J Biochem Cell Biol"},{"key":"230_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/ijms18061157","volume":"18","author":"L Zhou","year":"2017","unstructured":"Zhou L, Gao R, Wang Y, Zhou M, Ding Z. Loss of BAX by miR-365 promotes cutaneous squamous cell carcinoma progression by suppressing apoptosis. Int J Mol Sci. 2017;18:1157.","journal-title":"Int J Mol Sci"},{"key":"230_CR25","first-page":"1096","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y, Xu C, Wang Y, Zhang X. MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a. Am J Cancer Res. 2017;7:1096\u2013106.","journal-title":"Am J Cancer Res"},{"key":"230_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.placenta.2016.07.004","volume":"45","author":"A Mori","year":"2016","unstructured":"Mori A, Nishi H, Sasaki T, Nagamitsu Y, Kawaguchi R, Okamoto A, Kuroda M, Isaka K. HLA-G expression is regulated by miR-365 in trophoblasts under hypoxic conditions. Placenta. 2016;45:37\u201341.","journal-title":"Placenta"},{"key":"230_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/ijms17040436","volume":"17","author":"X Yang","year":"2016","unstructured":"Yang X, Guan Y, Tian S, Wang Y, Sun K, Chen Q. Mechanical and IL-1beta responsive miR-365 contributes to osteoarthritis development by targeting histone deacetylase 4. Int J Mol Sci. 2016;17:436.","journal-title":"Int J Mol Sci"},{"key":"230_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.7150\/ijms.8938","volume":"11","author":"P Zhang","year":"2014","unstructured":"Zhang P, Zheng C, Ye H, Teng Y, Zheng B, Yang X, Zhang J. MicroRNA-365 inhibits vascular smooth muscle cell proliferation through targeting cyclin D1. Int J Med Sci. 2014;11:765\u201370.","journal-title":"Int J Med Sci"},{"key":"230_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.exer.2017.11.006","volume":"168","author":"J Wang","year":"2018","unstructured":"Wang J, Zhang J, Chen X, Yang Y, Wang F, Li W, Awuti M, Sun Y, Lian C, Li Z, et al. miR-365 promotes diabetic retinopathy through inhibiting Timp3 and increasing oxidative stress. Exp Eye Res. 2018;168:89\u201399.","journal-title":"Exp Eye Res"},{"key":"230_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbrc.2017.01.108","volume":"484","author":"H Wu","year":"2017","unstructured":"Wu H, Wang Y, Wang X, Li R, Yin D. MicroRNA-365 accelerates cardiac hypertrophy by inhibiting autophagy via the modulation of Skp2 expression. Biochem Biophys Res Commun. 2017;484:304\u201310.","journal-title":"Biochem Biophys Res Commun"},{"key":"230_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/21691401.2018.1457040","volume":"46","author":"Y Sa","year":"2018","unstructured":"Sa Y, Wang L, Shu H, Gu J. Post-transcriptional suppression of TIMP-1 in epithelial-differentiated adipose-derived stem cells seeded bladder acellular matrix grafts reduces urethral scar formation. Artif Cells Nanomed Biotechnol. 2018;46:306\u201313.","journal-title":"Artif Cells Nanomed Biotechnol"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-019-0230-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40659-019-0230-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-019-0230-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T23:18:51Z","timestamp":1586992731000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-019-0230-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1186\/s40659-019-0230-y","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"29 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}